Schrodinger Other Non-Current Liabilities 2019-2024 | SDGR

Schrodinger other non-current liabilities from 2019 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Schrodinger Annual Other Non-Current Liabilities
(Millions of US $)
2023 $1
2022 $1
2021 $0
2020 $1
2019 $1
2018 $
Schrodinger Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $0
2024-06-30 $0
2024-03-31 $1
2023-12-31 $1
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $1
2022-06-30 $1
2022-03-31 $1
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $1
2020-12-31 $1
2020-09-30 $1
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.895B $0.217B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.209B 54.83
Hims & Hers Health (HIMS) United States $15.018B 381.89
Tempus AI (TEM) United States $13.495B 0.00
Inspire Medical Systems (INSP) United States $5.303B 103.31
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
MSP Recovery (MSPR) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00